These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 6172339)

  • 1. [Infection prophylaxis in granulocytopenia by clinical gnotobiotics].
    Günther I; Bohnenstengel C; Brijmohan-Günther R; Konrad H
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1981; 108(5):715-20. PubMed ID: 6172339
    [No Abstract]   [Full Text] [Related]  

  • 2. [Treatment of neoplasms and agronulocytosis in germ-free space].
    Nagel GA; Stöklin EJ; MULLER A
    Schweiz Med Wochenschr; 1974 Dec; 104(50):1868-70. PubMed ID: 4614434
    [No Abstract]   [Full Text] [Related]  

  • 3. [Reverse isolation and gnotobiotics].
    Meindersma TE
    Ned Tijdschr Geneeskd; 1971 Mar; 115(10):422-9. PubMed ID: 4925676
    [No Abstract]   [Full Text] [Related]  

  • 4. [Low-green environment for the overcoming of granulocytopenic stages in leukemia therapy].
    Wendt F; Grüning B; Lenz B; Brittinger G; Linzenmeier G
    Verh Dtsch Ges Inn Med; 1969; 75():916-20. PubMed ID: 4993911
    [No Abstract]   [Full Text] [Related]  

  • 5. [Indications and choice of antibacterial treatment in patients receiving immunosuppressive agents and antimitotic drugs (author's transl)].
    Frottier J; Kernbaum S; Verliac F; Bastin R
    Pathol Biol (Paris); 1976 Feb; 24(2):141-8. PubMed ID: 775407
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Granulocytopenia and infections during induction therapy of acute leukemia].
    Ly B; Solheim BG; Skar AG
    Tidsskr Nor Laegeforen; 1981 Feb; 101(6):379-86. PubMed ID: 7209927
    [No Abstract]   [Full Text] [Related]  

  • 7. Protected environments and prophylactic antibiotics. A prospective controlled study of their utility in the therapy of acute leukemia.
    Levine AS; Siegel SE; Schreiber AD; Hauser J; Preisler H; Goldstein IM; Seidler F; Simon R; Perry S; Bennett JE; Henderson ES
    N Engl J Med; 1973 Mar; 288(10):477-83. PubMed ID: 4630706
    [No Abstract]   [Full Text] [Related]  

  • 8. Protected environment--prophylactic antibiotic programmes; clinical studies.
    Levine AS
    Clin Haematol; 1976 Jun; 5(2):409-24. PubMed ID: 939058
    [No Abstract]   [Full Text] [Related]  

  • 9. [Clinical gnotobiotics in hematology].
    Dietrich M
    Blut; 1974 May; 28(5):317-20. PubMed ID: 4422434
    [No Abstract]   [Full Text] [Related]  

  • 10. [Germ-reducing and controlling measurements (gnotobiotics) in patients with neoplasms endangered by infections and treated with cytostatic drugs].
    Matthias M; Tanneberger S
    Dtsch Gesundheitsw; 1972 Nov; 27(44):2074-80. PubMed ID: 4631592
    [No Abstract]   [Full Text] [Related]  

  • 11. [Antimicrobial therapy in secondary granulocytopenia after antineoplastic chemotherapy].
    Klener P; Vondrácek V
    Vnitr Lek; 1979 Dec; 25(12):1211-6. PubMed ID: 524767
    [No Abstract]   [Full Text] [Related]  

  • 12. Gnotobiotics in hematology: improvement of treatment of acute leukemia.
    Dietrich M
    Eur J Cancer (1965); 1975 Aug; 11suppl():49-55. PubMed ID: 815092
    [No Abstract]   [Full Text] [Related]  

  • 13. [The "sterile unit" (author's transl)].
    Meunier-Carpentier F
    Rev Med Brux; 1981 Nov; 2(9):865-9. PubMed ID: 6798665
    [No Abstract]   [Full Text] [Related]  

  • 14. Histocompatible leukocyte transfusion during granulocytopenia.
    Koza I; Holland JF; Cohen E
    Neoplasma; 1971; 18(2):185-91. PubMed ID: 5577316
    [No Abstract]   [Full Text] [Related]  

  • 15. [Prevention of infection in patients with agranulocytosis through isolation and whole-body decontamination].
    Fopp M; Gasser A; Eigenmann B; Jungi WF; Meuret G; Senn HJ
    Schweiz Med Wochenschr; 1975 Aug; 105(35):1123-5. PubMed ID: 808849
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Prevention of infection in agranulocytosis: 1st experiences with patient isolation and whole body decontamination. Preliminary report].
    Nagel GA; Martin R; Seiler W; Mayr AC; Koelz A
    Schweiz Med Wochenschr; 1974 Jan; 104(4):148-9. PubMed ID: 4590410
    [No Abstract]   [Full Text] [Related]  

  • 17. Microbial isolators for use in the hospital.
    Trexler PC
    Biomed Eng; 1975 Feb; 10(2):63-7. PubMed ID: 803845
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Pharmacotoxic aspects of antiblastic chemotherapeutic agents in hematological oncology].
    Cacciola E; Alessi M; Raimondo V
    Clin Ter; 1979 Nov; 91(4):339-50. PubMed ID: 540482
    [No Abstract]   [Full Text] [Related]  

  • 19. [Cefotiam in infections of granulocytopenic tumor patients].
    Spors S; Seng P; Nossek L
    Med Welt; 1982 Dec; 33(48):1749-50. PubMed ID: 6296600
    [No Abstract]   [Full Text] [Related]  

  • 20. Protocol for an evaluative study of the protective effect of isolation systems and decontamination in patients with high susceptibility to infection.
    Eur J Cancer (1965); 1972 Aug; 8(4):367-71. PubMed ID: 5073299
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.